|
The continuous
availability of the appropriate drugs and diagnostics of assured quality is
a prerequisite for scaling up treatment, as well as for sustaining existing
treatment programmes and efforts. Moreover, in order to ensure access to
treatment, these drugs should be affordable to the individual and to the
health system.
Therefore programmes should aim to procure
quality products at the best possible prices, taking into account that some
HIV/AIDS drugs are relatively new and may be protected by patents.
Moreover, the distribution and supply of drugs and diagnostics should be
managed effectively.
 Procurement,
prequalification, diagnostics
Supply
management of HIV drugs and diagnostics
Patents and
intellectual property laws
|
